Lindus Health Competitive Intelligence & Landscape

Lindus Health is a next-generation Contract Research Organization (CRO) that specializes in delivering faster, more reliable clinical trials for the life sciences industry. Founded recently, the company is headquartered in Boston, Massachusetts, and has experienced significant growth, with 164 employees and annual revenues of approximately $27.5 million as of 2026 (Exa, Clay). Lindus Health distinguishes itself as an anti-CRO by combining a world-class clinical operations team with an AI-powered software platform, access to over 40 million Electronic Health Records, and a commercial model that aligns incentives through fixed-price quotes and milestone-based payments (Exa).

The company's core services encompass end-to-end clinical trial management, including protocol design, patient recruitment, clinical data capture, monitoring, and project management. Its mission is to revolutionize the clinical trial process by eliminating delays, reducing costs, and increasing reliability, thereby accelerating the development of new health and biotech treatments (Exa, Result 4). Lindus Health targets healthcare and biotech companies seeking innovative solutions to traditional clinical research challenges, competing with firms like Objectivity and CSI (Exa). The company has raised over $79 million in funding, with its latest round being a grant in 2025, reflecting strong investor confidence (Clay). Overall, Lindus Health aims to transform healthcare research by providing faster, more efficient clinical trial services backed by advanced technology and a clear value proposition.

Lindus Health offers a transparent, fixed pricing model for its clinical trial services, emphasizing aligned incentives to avoid additional costs due to delays or overruns (lindushealth.com). While specific details about tiered plans or features are not explicitly outlined, the company promotes a straightforward pricing structure that is designed to be predictable and cost-effective for sponsors. Recent updates or changes to their pricing plans are not detailed, but their focus remains on delivering end-to-end clinical trial solutions with clear, fixed costs (lindushealth.com).

In addition to Lindus Health, related platforms like Lindy.ai provide various pricing plans, including a free trial period and tiered paid options, with the most comprehensive plans costing around $8,000 per month for human assistant services (lindy.ai). However, these are separate from Lindus Health’s offerings. For the most accurate and current pricing details, visiting Lindus Health’s official website or contacting their sales team is recommended, as specific tiers and features may vary based on client needs and project scope.

Lindus Health has demonstrated significant growth in recent months, with a 74.4% year-over-year increase in its workforce, now employing between 51 and 200 staff members (source). The company is actively expanding its team, particularly in roles related to clinical trial management, software engineering, and product development, reflecting its strategic focus on revolutionizing clinical research processes (source). Recent hiring trends indicate a proactive approach to building a high-growth, innovative organization aimed at delivering faster, more reliable clinical trials for biotech and healthcare clients.

Despite the rapid growth and active hiring, there is no publicly available information indicating layoffs at Lindus Health as of March 2026. The company's emphasis on scaling its operations and its recent funding rounds, including a grant in May 2025, suggest a strategic focus on long-term expansion rather than downsizing (source). The company's hiring patterns—focused on transparency, curiosity, and high agency—signal a strategic intent to foster an innovative, agile, and mission-driven culture aligned with its goal to improve clinical trial efficiency and patient participation (source). Overall, Lindus Health’s recent hiring activity and growth trajectory point to a company committed to scaling its impact in the clinical research industry through strategic talent acquisition.

Lindus Health is a clinical research organization (CRO) that provides services and technology for managing clinical trials, including central monitoring of study data Lindus Health Stock (LIHA). The company was founded in 2021 and is headquartered in New York, NY, with operations also noted in Boston, Massachusetts Lindus Health Stock (LIHA), Lindus Health Revenue, Funding & Valuation.

Lindus Health offers a range of services such as ethics, IRB submission, trial monitoring, data management, biostatistics, regulatory affairs, and payor affairs, alongside products for EDC, database management, site operations, and feasibility studies Lindus Health Stock (LIHA).

Financially, Lindus Health has an estimated annual revenue of $27,500,000 and an estimated valuation of $88,000,000 Lindus Health Revenue, Funding & Valuation. The company has raised a total of $73,000,000 across 3 funding rounds, with a revenue per employee estimated at $140,000 Lindus Health Revenue, Funding & Valuation.

Lindus Health employs between 101-200 individuals Lindus Health Revenue, Funding & Valuation.

Recent recognition for Lindus Health includes being named a Fierce CRO Award Winner in the Outstanding Patient Recruitment and Retention Category, and for transforming patient recruitment with AI-powered precision, as reported in June 2025 Lindus Health Stock (LIHA). The company's funding and investor information indicates it has raised approximately $78 million from 24 investors, with a Series B funding round occurring in 2021 Lindus Health funding & investors. There is no readily available information regarding M&A activity for Lindus Health in the provided search results.

Lindus Health actively participates in various industry events, including webinars and conferences, to showcase its innovative clinical research solutions. Notably, they host webinars such as the one scheduled for March 24, 2026, titled "Beyond FEV1: Similar Efficacy, Different Outcome," which focuses on accelerating payor-ready evidence through faster recruitment and broader patient populations in respiratory research (lindushealth.com). Additionally, Lindus Health hosts webinars on specific topics like medical device trials, with an upcoming session on June 24, 2026, aimed at discussing common pitfalls in medical device clinical trials (lindushealth.com). While detailed information about their attendance or sponsorship of trade shows and community events is not explicitly provided in the search results, their active hosting of webinars indicates a strong presence in educational and industry-specific digital events, aligning with their role as a next-generation CRO for life sciences (lindushealth.com).